Efficacy of Low-Dose Bepridil for Prevention of Ventricular Fibrillation in Patients With Brugada Syndrome With and Without SCN5A Mutation-Reference-Cited by-同舟云学术

Efficacy of Low-Dose Bepridil for Prevention of Ventricular Fibrillation in Patients With Brugada Syndrome With and Without SCN5A Mutation

Published:2010-10 Issue:4 Volume:56 Page:389-395
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Murakami Masato,Nakamura Kazufumi,Kusano Kengo F,Morita Hiroshi,Nakagawa Koji,Tanaka Masamichi,Tada Takeshi,Toh Norihisa,Nishii Nobuhiro,Nagase Satoshi,Hata Yoshiki,Kohno Kunihisa,Miura Daiji,Ohe Tohru,Ito Hiroshi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference31 articles.

1. Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome.;Alings;Pacing Clin Electrophysiol,2001

2. Efficacy of quinidine in high-risk patients with Brugada syndrome.;Belhassen;Circulation,2004

3. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.;Mizusawa;J Cardiovasc Pharmacol,2006

4. Effects of the calcium entry blocker bepridil on repolarizing and pacemaker currents in sheep cardiac Purkinje fibres.;Berger;Naunyn Schmiedebergs Arch Pharmacol,1989

5. Repolarization dynamics in patients with idiopathic ventricular fibrillation: pharmacological therapy with bepridil and disopyramide.;Sugao;J Cardiovasc Pharmacol,2005

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Brugada syndrome: pharmacological therapy;European Heart Journal Supplements;2023-04-26

2. JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias;Circulation Journal;2022-10-25

3. JCS / JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias;Journal of Arrhythmia;2022-10-25

4. Bepridil monotherapy failed to prevent coronary vasospasm in a Brugada syndrome patient;OXF MED CASE REP;2022

5. J wave syndrome: Benign or malignant?;ARYA ATHEROSCLER;2021